[Insulin-like growth factor binding protein-3 (IGFBP-3)]. 2005

Kazuhiro Takeoshi, and Toshiaki Nakai
Department of Clinical Pathology, Institute of Clinical Medicine, University of Tsukuba.

UI MeSH Term Description Entries
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D011933 Reagent Kits, Diagnostic Commercially prepared reagent sets, with accessory devices, containing all of the major components and literature necessary to perform one or more designated diagnostic tests or procedures. They may be for laboratory or personal use. Diagnostic Reagent Kits,Diagnostic Reagents and Test Kits,Diagnostic Test Kits,In Vitro Diagnostic Device,In Vitro Diagnostic Devices,In Vitro Diagnostic Medical Device,In Vitro Diagnostic Medical Devices,Kits, Diagnostic Reagent,Diagnostic Reagent Kit,Diagnostic Test Kit,Kit, Diagnostic Reagent,Kit, Diagnostic Test,Kits, Diagnostic Test,Reagent Kit, Diagnostic,Test Kit, Diagnostic,Test Kits, Diagnostic
D003940 Diagnostic Techniques, Endocrine Methods and procedures for the diagnosis of diseases or dysfunction of the endocrine glands or demonstration of their physiological processes. Diagnostic Technic, Endocrine,Diagnostic Technics, Endocrine,Diagnostic Technique, Endocrine,Endocrine Diagnostic Technic,Endocrine Diagnostic Technics,Endocrine Diagnostic Technique,Endocrine Diagnostic Techniques,Technic, Endocrine Diagnostic,Technics, Endocrine Diagnostic,Technique, Endocrine Diagnostic,Techniques, Endocrine Diagnostic
D004393 Dwarfism, Pituitary A form of dwarfism caused by complete or partial GROWTH HORMONE deficiency, resulting from either the lack of GROWTH HORMONE-RELEASING FACTOR from the HYPOTHALAMUS or from the mutations in the growth hormone gene (GH1) in the PITUITARY GLAND. It is also known as Type I pituitary dwarfism. Human hypophysial dwarf is caused by a deficiency of HUMAN GROWTH HORMONE during development. Growth Hormone Deficiency Dwarfism,Hypophysial Dwarf,Hyposomatotrophic Dwarfism,Pituitary Dwarf,Dwarfism, Growth Hormone Deficiency,Isolated GH Deficiency,Isolated Growth Hormone Deficiency,Isolated HGH Deficiency,Isolated Human Growth Hormone Deficiency,Isolated Somatotropin Deficiency,Isolated Somatotropin Deficiency Disorder,Nanism, Pituitary,Pituitary Dwarfism,Pituitary Nanism
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000375 Aging The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time. Senescence,Aging, Biological,Biological Aging
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D018972 Insulin-Like Growth Factor Binding Protein 3 One of the six homologous soluble proteins that bind insulin-like growth factors (SOMATOMEDINS) and modulate their mitogenic and metabolic actions at the cellular level. IGF-Binding Protein 3,IGFBP-3,IGF Binding Protein 3,Protein 3, IGF-Binding

Related Publications

Kazuhiro Takeoshi, and Toshiaki Nakai
December 1999, Nihon rinsho. Japanese journal of clinical medicine,
Kazuhiro Takeoshi, and Toshiaki Nakai
October 2015, Best practice & research. Clinical endocrinology & metabolism,
Kazuhiro Takeoshi, and Toshiaki Nakai
August 2004, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society,
Kazuhiro Takeoshi, and Toshiaki Nakai
July 2010, Nihon rinsho. Japanese journal of clinical medicine,
Kazuhiro Takeoshi, and Toshiaki Nakai
December 1999, Endocrine reviews,
Kazuhiro Takeoshi, and Toshiaki Nakai
June 2000, The Journal of clinical endocrinology and metabolism,
Kazuhiro Takeoshi, and Toshiaki Nakai
August 2013, Journal of cell communication and signaling,
Kazuhiro Takeoshi, and Toshiaki Nakai
June 2015, Journal of cell communication and signaling,
Kazuhiro Takeoshi, and Toshiaki Nakai
January 2002, Journal of endocrinological investigation,
Copied contents to your clipboard!